Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Legislators look to repeal medical device tax

Momentum is growing in Congress to repeal taxes on medical device sales, reports The Hill.

Thumbnail

Medicare's policy not to pay for HACs appears to be working

Medicare's policy not to pay for the treatment of hospital-acquired infections appears to be making an impact, according to Medscape.   

Harvard feels consequences of own ideas on healthcare reform

Harvard faculty are in an uproar over rising healthcare costs, even as the school's very own economists and health policy advisors had championed heathcare reform efforts, reports The New York Times. 

Accenture wins $563M federal contract

Accenture Federal Services has won a five-year, $563 million contract to continue its work on Healthcare.gov, reports Clinical Innovation + Technology.

Thumbnail

HHS awards $665M to test new delivery models

The Department of Health & Human Services is awarding more than $665 million in Affordable Care Act monies to design and test healthcare payment and service delivery models. 

Meaningful Use Stage 2 attestations remain lackluster

Data released by the Centers for Medicare & Medicaid Services at the Health IT Policy Committee reveal only marginal gains in the numbers of eligible professionals and hospitals attesting to Meaningful Use Stage 2, reports Clinical Innovation + Technology.

Federal Health IT Strategic Plan unveiled

The Office of the National Coordinator for Health IT has published the Federal Health IT Strategic Plan 2015-2020, updating the original 2011 version, reports Clinical Innovation + Technology. 

Thumbnail

Federal contractors finding work in healthcare, not war

Diminishing wars and a drop in defense spending are spurring federal contractors to expand their businesses related to healthcare, reports The Washington Post. 

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup